腹膜透析患者骨骼肌减少症的诊治进展  

Diagnosis and treatment of sarcopenia in patients undergoing peritoneal dialysis

作　　者：吴佳盈 沈水娟 吴秀娟 官继超 丁苗佳 Wu Jiaying;Shen Shuijuan;Wu Xiujuan;Guan Jichao;Ding Miaojia(Graduate School,Shaoxing University School of Medicine,Shaoxing 312000,China;Department of Nephrology,the First Affiliated Hospital of Shaoxing University,Shaoxing People′s Hospital,Shaoxing 312000,China)

机构地区：[1]绍兴文理学院医学院研究生院,绍兴312000 [2]绍兴文理学院附属第一医院绍兴市人民医院肾内科,绍兴312000

出　　处：《中华全科医师杂志》2022年第7期691-695,共5页Chinese Journal of General Practitioners

基　　金：浙江省医药卫生科技计划项目(2022KY399);绍兴市人民医院青年基金项目(2021YB26)。

摘　　要：骨骼肌减少症(肌少症)以肌肉质量减少、力量减退、功能下降为主要表现,因其知晓率低、治疗率低,心血管风险高,严重影响患者生命质量及临床预后。尿毒症腹膜透析患者受饮食限制、蛋白质丢失及高分解代谢等多种因素影响,易患肌少症。文章对腹膜透析患者肌少症的诊断技术和方法、危险因素、预测标志物、干预措施等研究进展进行综述。Sarcopenia is a systemic syndrome characterized by decreased muscle mass and muscle strength and decline of motor function.Sarcopenia affects quality of life and disease prognosis of patients seriously,because of the low awareness rate,low treatment rate and high cardiovascular risk.Patients with uremia undergoing peritoneal dialysis are likely to suffer from sarcopenia due to dietary restriction,loss of protein and high catabolism.This article summarizes the diagnostic methods,risk factors,predictive markers and intervention measures for sarcopenia in peritoneal dialysis patients.

关 键 词：腹膜透析 肌少症 诊断技术和方法 危险因素 预测 

分 类 号：R692.5[医药卫生—泌尿科学] R685[医药卫生—外科学]